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Abstract
Objective. Chronic periaortitis (CP) is a rare disease characterized by fibro-inflammatory tissue surround-
ing the abdominal aorta and the iliac arteries. Anecdotal reports have shown that CP may also involve
other vascular districts, particularly the thoracic aorta. The aim of this study was to investigate the thoracic
aorta and epiaortic artery involvement in CP.
Methods. Patients were eligible if they had undergone imaging studies assessing inflammatory involve-
ment of the thoracic aorta and its major branches (e.g. contrast CT, MRI or PET-CT). We explored the
patterns of thoracic vessel involvement and compared the clinical characteristics of patients with and
without thoracic disease. Where available, we also reviewed the thoracic vascular/perivascular tissue
biopsies.
Results. Of 153 CP patients seen between 1999 and 2012, 77 were eligible. Of these, 28 (36%) had
thoracic involvement: 15 (54%) had thoracic periaortitis, with 7 also showing epiaortic artery involvement;
6 (21%) had periaortitis surrounding a thoracic aortic aneurysm, 2 of them with epiaortic artery involve-
ment; 7 (25%) had a thoracic aortic aneurysm without periaortitis. Patients with thoracic disease were
more frequently female (P= 0.01), were older (P= 0.001) and had a higher frequency of pain and consti-
tutional symptoms (P= 0.02). Thoracic (peri)vascular biopsies revealed adventitial and peri-adventitial fibro-
inflammatory patterns similar to those observed in abdominal CP.
Conclusion. In about one-third of patients, CP also involves the thoracic aorta and the epiaortic arteries,
which supports the hypothesis of a systemic inflammatory disease of the large arteries.
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Rheumatology key messages
. In one-third of patients, chronic periaortitis involves the thoracic aorta and/or the epiaortic arteries.
. Chronic periaortitis patients with thoracic aorta involvement are more frequently symptomatic, female and elderly.
. Chronic periaortitis with thoracic aorta involvement has features of a systemic large vessel vasculitis.
Introduction
Chronic periaortitis (CP) is a rare disease characterized
by fibro-inflammatory tissue spreading from the abdominal
aorta and the iliac arteries into the surrounding retroperito-
neum. CP includes non-aneurysmal [idiopathic retroperi-
toneal fibrosis (IRF)] and aneurysmal forms [inflammatory
abdominal aortic aneurysms (IAAAs), perianeurysmal
retroperitoneal fibrosis (PRF)] [13]. Histology reveals pro-
nounced fibrosis and a chronic inflammatory infiltrate [4],
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and in some cases IgG4+ plasma cell infiltration, which is
why CP is included in the spectrum of IgG4-related disease
(IgG4-RD), a newly recognized condition that often in-
volves other sites (e.g. pancreas, salivary glands) [5].
CP was initially thought to result from a localized inflam-
matory response to aortic atherosclerotic plaque antigens
[3], but recent findings including the association with other
autoimmune diseases and with HLA-DRB1*03 and the
presence of systemic clinical manifestations [2, 6] suggest
a systemic immune-mediated origin. This hypothesis is
reinforced by descriptions of CP involving not only the
abdominal aorta, but also other vascular areas (e.g. thor-
acic aorta) [7, 8]. We here explored the frequency and
patterns of involvement of the thoracic aorta and epiaortic
arteries in CP patients and investigated whether CP with
thoracic vessel involvement represents a distinct disease
form.
Patients and methods
Eligibility criteria, imaging and laboratory
examinations
Between 1999 and 2012, 153 consecutive CP patients
were seen at our centre. CP was diagnosed by abdominal
CT or MRI, following commonly accepted criteria [9].
When available, whole-body [18F]fluorodeoxyglucose
(18F-FDG) PET was also performed. Retroperitoneal and/
or abdominal aortic biopsies were performed in patients
undergoing ureterolysis or aortic aneurysmectomy and in
those with atypical disease localization. Patients under-
went routine clinical and laboratory examinations includ-
ing ESR, CRP and a panel of autoantibodies [10]. IgG4
levels (normal, 8140 mg/dl) were assessed in a fraction
of patients, as this test became available at our centre in
2007. We excluded secondary causes of retroperitoneal
fibrosis (e.g. drugs, malignancies, ErdheimChester dis-
ease) [11], genetically determined diseases causing
aortic aneurysms (e.g. Marfan’s, Turner’s and
EhlersDanlos syndromes), infectious aortitis, GCA and
Takayasu’s arteritis (TA) [12].
CP patients were eligible for this study if they had ap-
propriate imaging studies examining the inflammatory in-
volvement of the thoracic aorta and its major branches,
which included contrast-enhanced chest CT or MRI and
whole-body 18F-FDG PET-CT. CT was performed with a
multidetector scanner (1 mm sections) before and after
contrast medium injection in arterial and venous phases.
Chest MRI studies were performed with a 1.5T MRI
system using a phased array torso coil. We examined
axial T1- and T2-weighted, fat- and non-fat-suppressed
imaging sequences. A T1-weighted three-dimensional
gradient echo sequence in the axial plane was performed
with fat suppression 35 and 90 s from the beginning of
contrast injection. The radiologist evaluated the presence
of the perivascular tissue, its thickness, MRI/CT features
and contrast enhancement using a region of interest. The
aortic diameter was measured (not including the vessel
wall) using multiplanar reformatted imaging. On PET, vas-
cular FDG uptake was graded using a 4-point scale: 0, no
uptake; 1, low-grade uptake (lower than liver uptake); 2,
intermediate-grade uptake (similar to liver uptake); and 3,
high-grade uptake (between liver and cerebral uptake or
similar to the uptake in the cerebral cortex). Scores of 01
were considered negative, while scores of 23 were con-
sidered positive. The study was approved by the ethics
committee of the University Hospital of Parma (Comitato
Etico per Parma). All participants signed an informed con-
sent form. Privacy was preserved through the adoption of
alphanumeric codes as identifiers.
Histological analysis of CP biopsies
Retroperitoneal or abdominal aortic biopsies and, when
available, thoracic aorta or carotid artery biopsies (in pa-
tients undergoing aortic aneurysmectomy or carotid end-
arterectomy) were analysed for diagnostic purposes as
previously described [4]. The slides were stained using
routine techniques [4]. The degree of IgG4+ plasma cell
infiltration was assessed by calculating the IgG4+:CD138+
cell ratio [11].
Statistical analysis
Categorical data were reported as proportions and com-
pared by Fisher’s exact test. Continuous data were
reported as mean (S.D.) or median [interquartile range
(IQR)] and compared by Student’s t-test or
MannWhitney test as appropriate. A two-sided P-value
<0.05 was considered statistically significant. All analyses
were done using SPSS 20.0 (SPSS, Chicago, IL, USA).
Results
Thoracic vessel disease patterns in CP
Of the 153 patients screened, 77 were eligible for this
study; 69 had IRF (Fig. 1A and B) and 8 had IAAA/PRF.
Twenty-eight cases (36%) showed thoracic aorta and/or
epiaortic artery involvement; this was diagnosed in 9/28
cases by contrast chest CT, in 4/28 by contrast MRI (2
completed the examination with contrast-enhanced mag-
netic resonance angiography) and in 15/28 by 18F-FDG
PET-CT.
In these 28 cases, the following patterns of thoracic
vessel involvement were identified (Fig. 1). Thoracic peri-
aortitis (15/28 patients, 54%) had the hallmark of a peri-
vascular soft tissue mass surrounding a thoracic aorta of
normal calibre. The tissue was usually homogeneous with
no infiltrative features. On non-enhanced CT, its density
was similar to that of the thoracic wall muscles. The tissue
had low signal intensity on T1-weighted MRI, whereas on
T2-weighted scans the signal intensity was usually high.
The perivascular tissue enhancement was variable on CT/
MRI, probably reflecting disease activity: it was early and
avid during active phases and non-significant during in-
active phases. On PET, the median 18F-FDG uptake grade
was 3+ (IQR 34+) around the abdominal aorta and 3+
(IQR 34+) around the thoracic aorta. In 13/15 cases
with thoracic periaortitis the perivascular tissue sur-
rounded the ascending aorta, the aortic arch and the
upper descending aorta (Fig. 1CE and GI), whereas in
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FIG. 1 Imaging findings in chronic periaortitis patients with thoracic aorta involvement
(A) CT appearance of non-aneurysmal chronic periaortitis (idiopathic retroperitoneal fibrosis). A soft-tissue density mass
surrounds the anterior and lateral sides of the abdominal aorta (arrows). (B) The periaortic mass seen in (A) extends to
surround both common iliac arteries (arrows) and also encases the ureters where stents are placed. (CE) CT appearance
of thoracic periaortitis. The perivascular tissue surrounds (C) the ascending aorta (arrows), (D) the aortic arch (arrows) and
(E) the upper portion of the descending thoracic aorta (arrow). (F) CT appearance of the perivascular tissue that involves
the origin of the carotid arteries (arrows). (G) Multiplanar reformatted imaging CT appearance of periaortitis in a sagittal
view that involves the ascending thoracic aorta (left arrow), the origin of the epiaortic vessels (short arrow) and the
descending aorta (right arrow). (H and I) MRI appearance (T1- and T2-weighted scans, respectively) of thoracic peri-
aortitis. In this patient, perivascular tissue is present around the ascending aorta. The perivascular tissue surrounding the
ascending aorta is hypointense in both T1- and T2-weighted scans, reflecting an inactive phase of the disease.
2006 www.rheumatology.oxfordjournals.org
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2 cases it involved the lower descending aorta. Seven of
15 patients also showed perivascular involvement of the
origin of the epiaortic arteries (common carotid in 5, left
subclavian in 1 and brachiocephalic in 1) (Fig. 1F). In
thoracic aortic aneurysm with periaortitis [6/28 cases
(21%)], the characteristics of the perivascular tissue
were similar to those described above, but the thoracic
aorta showed aneurysmal dilatation (>50% of the ex-
pected normal diameter). Epiaortic vessel involvement
was found in two cases (common carotid arteries in
both and left subclavian in one). In thoracic aortic aneur-
ysm without periaortitis [7/28 patients (25%)], the aneur-
ysm involved the ascending aorta in 5 cases, the aortic
arch and descending aorta in 1, and the ascending aorta,
the aortic arch and the descending aorta in 1. We included
thoracic aortic aneurysm without periaortitis as a disease-
related manifestation because it is a potential complica-
tion of large vessel vasculitides.
Thoracic vessel disease was symptomatic in only
four patients (14%); in these cases thoracic periaortitis
was always associated with epiaortic involvement. Two
patients had hoarseness secondary to recurrent laryn-
geal nerve paralysis. Unilateral deficit in arm strength,
asymmetrical pulses/blood pressure values were
observed in two patients and arm claudication, upper
limb paresthesias and dry cough were found in three
patients. Four patients underwent thoracic aneurysm
repair (two surgical, two endovascular) and two carotid
endoarterectomy.
CP histology
Retroperitoneal biopsies were available in 46% of patients
with and 47% of patients without thoracic involvement,
whereas thoracic CP biopsies were available in three pa-
tients (two after carotid endarterectomy and one after sur-
gical repair of thoracic aortic aneurysm). Histological
examination of abdominal biopsies showed a typical CP
pattern and no differences in histological features were
found in patients with vs without thoracic involvement.
Histology of the thoracic tissue was strikingly similar to
that found in abdominal CP [4]. The pathological lesions
in thoracic CP involved the adventitia and the peri-
adventitial tissue and consisted of a fibrous component
and a chronic inflammatory infiltrate (supplementary Fig.
S1, available at Rheumatology Online), as described in
abdominal CP [2, 4]. The inflammatory infiltrate displayed
perivascular and diffuse patterns and consisted of
lymphocytes, histiocytes, plasma cells and eosinophils.
The follicular aggregates, often with germinal centres,
were rich in lymphocytes, which clustered around adven-
titial vasa vasorum (Supplementary Fig. S1, available at
Rheumatology Online). Immunohistochemistry revealed
in two of these three cases (one with thoracic periaortitis
and epiaortic artery involvement, the other with thoracic
periaortitis plus aneurysm) an IgG4+:CD138+ plasma
cell ratio >40% (the cut-off used to define CP as IgG4
related) [13].
Demographic, laboratory and clinical features in
patients with and without thoracic disease
Patients with thoracic involvement had a significantly
higher female prevalence (P= 0.01), a greater age at dis-
ease onset (P= 0.001), a higher prevalence of systemic
symptoms (e.g. fatigue, anorexia, weight loss) (P= 0.02)
and back or abdominal pain (P= 0.02) (Table 1). Patients
with thoracic disease also tended to have higher ESR and
CRP level than patients without thoracic disease, although
the differences were not statistically significant. Similar
proportions of patients in the two groups had other
autoimmune diseases, the most common of which were
autoimmune thyroiditis and psoriasis. IgG4 measurement
was available in 45/77 patients (58%); serum IgG4 levels
(data not shown) and the percentage of patients with high
IgG4 did not differ in the two groups (Table 1), so IgG4 did
not characterize a CP subset with more frequent
extraretroperitoneal lesions, in contrast to previously re-
ported data [13, 14].
Discussion
CP is usually thought to be confined to the abdominal
aorta and the iliac arteries and its pathogenesis is con-
sidered secondary to a localized inflammatory reaction to
atherosclerotic plaque antigens [3, 15]. Our study chal-
lenges this view and shows that in one-third of patients
it also involves the thoracic aorta and the epiaortic
arteries. This may suggest that in such cases, CP actually
represents a primary, diffuse inflammatory disease of the
aorta and its major branches.
Anecdotal reports have described in CP the occurrence
of periarteritis involving large arteries such as the coronary
[16, 17], renal, mesenteric and coeliac axis [18].
Interestingly, autopsy studies in CP showed adventitial
inflammation in aortic sections (mainly at the thoracic
aorta level) lacking periaortic fibrosis, suggesting the pres-
ence of widespread aortic disease and implying a transi-
tion from adventitial inflammation to fibrosis [7]. Molecular
analysis of CP biopsies revealed gene transcripts (IFN-g,
IL-2 and IL-4), indicating lymphocyte activation within the
aorta wall [19]. Finally, the pattern of vascular inflamma-
tion in CP is also consistent with an inflammatory vascular
disease: as in GCA and TA, inflammation in CP predom-
inates in the adventitia. This was seen on abdominal aortic
biopsies [3, 10] and also in the thoracic aortic biopsies
examined here, where the lymphomonocytic infiltrate typ-
ically involves the adventitia and the mediaadventitia
border. Adventitial vasa vasorum, a possible port of
entry for disease-triggering pathogens in GCA [20], are
often inflamed in CP; in addition, the observed adventitial
germinal centres are the expression of ectopic lympho-
neogenesis, a feature of many autoimmune diseases.
These findings suggest that CP may arise as a primary
large artery inflammatory disease, which in some patients
is localized to the abdominal aorta and iliac arteries and in
others extends to other vascular segments.
The patterns of large thoracic artery involvement ranged
from classic periaortitis—with or without aortic dilatation—to
www.rheumatology.oxfordjournals.org 2007
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thoracic aortic aneurysms without periaortitis. All these pat-
terns can be seen in other large vessel diseases, primarily
GCA and TA, which often affect not only the epiaortic tree,
but also the thoracic and abdominal aorta. GCA and TA
usually lack the thick periaortic cuff seen in CP, and GCA
features cranial symptoms (e.g. scalp tenderness, visual
abnormalities) that are almost absent in CP. However,
some GCA and TA patients present with isolated non-
specific manifestations, such as systemic symptoms, that
make the differential diagnosis more challenging. One
distinguishing feature between CP and GCA/TA is ureteral
involvement, which is only found in CP [9, 11].
When managing CP patients with thoracic aorta in-
volvement it is mandatory to exclude two other diseases
presenting with similar features: ErdheimChester
disease, a non-Langerhans cell histiocytosis, that pre-
sents with symmetrical long bone involvement and often
peri-renal fibrosis, and IgG4-RD. Recent reports have
shown that CP belongs to the spectrum of IgG4-RD, as
both IRF and IAAA are characterized, in 4050% of
cases, by numerous IgG4+-infiltrating plasma cells
[5, 13]. Two of the three thoracic aorta/carotid biopsies
available in our patients had significant IgG4+ plasma
cell infiltration, suggesting an overlap between CP and
IgG4-RD, but these patients lacked involvement of other
sites by IgG4-RD.
The comparison of demographic and clinical character-
istics of patients with and without thoracic involvement
revealed that these subgroups were different. Patients
with thoracic disease were more frequently female and
TABLE 1 Demographic and clinical findings in CP patients with and without involvement of the thoracic aorta and its
main branches
Thoracic
involvement (n= 28)
No thoracic
involvement (n= 49) P-value
Female, n (%) 14 (50) 10 (20) 0.01
Age, median (IQR), years 64.5 (58.369.5) 56 (5059) 0.001
Non-aneurysmal vs aneurysmal CP, n 25 vs 3 44 vs 5 1.00
Biopsy-proven CP (retroperitoneal biopsy), n (%) 13 (46) 23 (47) 0.81
Clinical manifestations, n (%)
Abdominal or lumbar pain 26 (93) 33/48 (69) 0.021
Systemic symptoms 24 (86) 28/47 (59) 0.020
Testicular manifestationsb 3/14 (21) 23/39 (59) 0.12
Deep vein thrombosis 4 (14) 8 (16) 1.00
Constipation 9 (32) 18/48 (37) 0.80
Renal-ureteral involvement, n (%)
Ureteral obstruction
Overall 21 (75) 32 (67) 0.45
Unilateral 8 (38) 18 (56) 0.26
Bilateral 13 (62) 14 (44) 0.26
Acute renal failure 13 (46) 18 (37) 0.47
Laboratory findings
ESR, median (IQR), mm/h 72 (4792) 55 (34.7589.75) 0.20
CRP, median (IQR), mg/l 22.9 (6.944.5) 16.2 (643.1) 0.59
Hb, median (IQR), g/dl 11.5 (10.513) 12.4 (11.213.3) 0.07
WBC, median (IQR),/mm3 6800 (57207355) 7110 (62208485) 0.33
Autoimmunity, n (%)
Associated autoimmune or inflammatory diseases 11 (39) 18 (37) 1.00
Positive ANA 4/26 (15) 13/45 (29) 0.26
Other positive autoantibodiesc 13/26 (50) 14/45 (31) 0.13
High serum IgG4 (>140 mg/dl) 3/13 (23) 7/32 (21) 0.71
CV risk factors and CV diseases
Fasting glucose, median (IQR), mg/dl 92 (8299) 90 (85.595) 0.12
Total cholesterol, median (IQR), mg/dl 191 (172214) 197 (162228) 0.47
No. of atherosclerotic risk factors,d median (IQR) 1.5 (14) 2 (14) 0.31
Established atherosclerotic disease,e n (%) 7 (25) 17 (35) 0.45
aSystemic symptoms include weight loss, anorexia, fever, fatigue, diffuse myalgias or arthralgias. bTesticular manifestations
include testicular pain, varicocele and hydrocele. cOther positive antibodies indicate one or more of the following: RF, ANCA,
anti-dsDNA, anti-thyroglobulin, anti-thyroperoxidase, anti-smooth muscle or anti-Ro(SSA)/La(SSB) antibodies. dAtherosclerotic
risk factors include hypertension, diabetes, BMI 530, smoking and hypercholesterolaemia. eEstablished atherosclerotic dis-
ease comprises ischaemic heart disease, cerebrovascular disease and peripheral arterial disease; these were recorded during
the entire follow-up. CP: chronic periaortitis; CV: cardiovascular; Hb: haemoglobin; IQR: interquartile range; WBC: white blood
cell.
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older—characteristics reminiscent of a GCA phenotype—
and the frequency of disease-related symptoms was also
higher in this group.
In conclusion, in about one-third of patients CP is not
limited to the abdominal aorta, but also involves the thor-
acic aorta and the epiaortic arteries. Active adventitial in-
flammation is seen in both thoracic and abdominal aorta
biopsies, a pattern that suggests that CP may be a pri-
mary large vessel inflammatory disease.
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